NASDAQ:PMD Psychemedics (PMD) Stock Price, News & Analysis $2.28 -0.01 (-0.44%) (As of 08/21/2024 ET) Add Compare Share Share Today's Range$2.26▼$2.2950-Day Range$1.64▼$2.4552-Week Range$1.63▼$4.99Volume37,595 shsAverage Volume14,534 shsMarket Capitalization$13.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Psychemedics alerts: Email Address Ad Investors AlleyGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck worries melt away...All because of one ETF paying a huge 22% dividend. About Psychemedics Stock (NASDAQ:PMD)Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.Read More PMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PMD Stock News HeadlinesAugust 13, 2024 | globenewswire.comPsychemedics Corporation Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | finance.yahoo.comPsychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common StockAugust 22, 2024 | Crypto 101 Media (Ad)Massive Crypto Selloff = Historic OpportunityStocks recently suffered the worst 1-day loss since 2022… Cryptos got hammered as well…But here's the fact everyone is missing… As of this writing, Bitcoin is still up 28% year to date…And it's up 84% in the last year. August 12, 2024 | globenewswire.comPsychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common StockJune 21, 2024 | globenewswire.comPsychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair TestingMay 17, 2024 | money.usnews.comPsychemedics Corp.May 16, 2024 | investing.comPsychemedics (PMD) Earnings Dates & ReportsMay 14, 2024 | msn.comPMD Stock Earnings: Psychemedics Reported Results for Q1 2024August 22, 2024 | Colonial Metals (Ad)Wanted Dead: PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.May 14, 2024 | sfgate.comPsychemedics: Q1 Earnings SnapshotMay 14, 2024 | globenewswire.comPsychemedics Corporation Reports First Quarter 2024 Financial ResultsApril 25, 2024 | finance.yahoo.comPsychemedics Corporation (PMD) Stock Price, News, Quote & History - Yahoo FinanceMarch 28, 2024 | investorplace.comPMD Stock Earnings: Psychemedics Reported Results for Q4 2023March 28, 2024 | globenewswire.comPsychemedics Corporation Reports 2023 Financial ResultsMarch 21, 2024 | globenewswire.comPsychemedics Recognized as a Top 10 Employee Health Testing Services ProviderJanuary 3, 2024 | bizjournals.comSmall cap drug testing company relocates HQ to DFW from MassachusettsJanuary 2, 2024 | msn.comMassachusetts drug testing firm targeting fentanyl relocates corporate HQ to DallasJanuary 2, 2024 | markets.businessinsider.comPsychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasSee More Headlines Receive PMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/23/2019Today8/22/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:PMD CUSIPN/A CIK806517 Webwww.psychemedics.com Phone(978) 206-8220Fax978-264-9236Employees140Year Founded1985Profitability EPS (Most Recent Fiscal Year)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,150,000.00 Net Margins-21.50% Pretax Margin-16.10% Return on Equity-65.78% Return on Assets-35.67% Debt Debt-to-Equity RatioN/A Current Ratio1.48 Quick Ratio1.48 Sales & Book Value Annual Sales$20.79 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book1.98Miscellaneous Outstanding Shares5,806,000Free Float4,413,000Market Cap$13.21 million OptionableNot Optionable Beta0.68 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Brian Hullinger (Age 56)President, CEO & Director Comp: $361.37kMs. Daniella Mehalik (Age 34)Vice President of Finance Comp: $126.41kMs. Shannon ShoemakerChief Revenue OfficerDr. Werner A. Baumgartner Ph.D.FounderMs. Annette BaumgartnerFounderMr. Michael Weisenhoff (Age 34)Principal Financial & Accounting Manager Mr. Patrick J. Kinney Jr.SecretaryMore ExecutivesKey CompetitorsRenalytixNASDAQ:RNLXConcord Medical ServicesNYSE:CCMOncology InstituteNASDAQ:TOIATI Physical TherapyNYSE:ATIPCareMaxNASDAQ:CMAXView All CompetitorsInstitutional OwnershipDimensional Fund Advisors LPSold 13,429 shares on 8/9/2024Ownership: 0.391%View All Institutional Transactions PMD Stock Analysis - Frequently Asked Questions How have PMD shares performed this year? Psychemedics' stock was trading at $2.96 on January 1st, 2024. Since then, PMD stock has decreased by 23.1% and is now trading at $2.2750. View the best growth stocks for 2024 here. How were Psychemedics' earnings last quarter? Psychemedics Co. (NASDAQ:PMD) issued its quarterly earnings results on Tuesday, April, 23rd. The company reported $0.11 EPS for the quarter. The firm had revenue of $9.82 million for the quarter. Psychemedics had a negative net margin of 21.50% and a negative trailing twelve-month return on equity of 65.78%. What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO? 6 employees have rated Psychemedics Chief Executive Officer Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among the company's employees. Who are Psychemedics' major shareholders? Top institutional shareholders of Psychemedics include Dimensional Fund Advisors LP (0.39%). View institutional ownership trends. How do I buy shares of Psychemedics? Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Psychemedics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD). This page (NASDAQ:PMD) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | SponsoredMy harrowing warning about Nvidia Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psychemedics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psychemedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
